Cargando…

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant

Detalles Bibliográficos
Autores principales: de Michelena, Paula, Torres, Ignacio, Ramos-García, Ángela, Gozalbes, Victoria, Ruiz, Nidia, Sanmartín, Ana, Botija, Pilar, Poujois, Sandrine, Huntley, Dixie, Albert, Eliseo, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863328/
https://www.ncbi.nlm.nih.gov/pubmed/35217106
http://dx.doi.org/10.1016/j.jinf.2022.02.022
_version_ 1784655217433772032
author de Michelena, Paula
Torres, Ignacio
Ramos-García, Ángela
Gozalbes, Victoria
Ruiz, Nidia
Sanmartín, Ana
Botija, Pilar
Poujois, Sandrine
Huntley, Dixie
Albert, Eliseo
Navarro, David
author_facet de Michelena, Paula
Torres, Ignacio
Ramos-García, Ángela
Gozalbes, Victoria
Ruiz, Nidia
Sanmartín, Ana
Botija, Pilar
Poujois, Sandrine
Huntley, Dixie
Albert, Eliseo
Navarro, David
author_sort de Michelena, Paula
collection PubMed
description
format Online
Article
Text
id pubmed-8863328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88633282022-02-23 Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant de Michelena, Paula Torres, Ignacio Ramos-García, Ángela Gozalbes, Victoria Ruiz, Nidia Sanmartín, Ana Botija, Pilar Poujois, Sandrine Huntley, Dixie Albert, Eliseo Navarro, David J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-05 2022-02-22 /pmc/articles/PMC8863328/ /pubmed/35217106 http://dx.doi.org/10.1016/j.jinf.2022.02.022 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
de Michelena, Paula
Torres, Ignacio
Ramos-García, Ángela
Gozalbes, Victoria
Ruiz, Nidia
Sanmartín, Ana
Botija, Pilar
Poujois, Sandrine
Huntley, Dixie
Albert, Eliseo
Navarro, David
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title_full Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title_fullStr Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title_full_unstemmed Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title_short Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
title_sort real-life performance of a covid-19 rapid antigen detection test targeting the sars-cov-2 nucleoprotein for diagnosis of covid-19 due to the omicron variant
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863328/
https://www.ncbi.nlm.nih.gov/pubmed/35217106
http://dx.doi.org/10.1016/j.jinf.2022.02.022
work_keys_str_mv AT demichelenapaula reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT torresignacio reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT ramosgarciaangela reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT gozalbesvictoria reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT ruiznidia reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT sanmartinana reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT botijapilar reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT poujoissandrine reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT huntleydixie reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT alberteliseo reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant
AT navarrodavid reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant